BioCorRx Inc.
BICX- Exchange
- OTC
- Industry
- Services-Specialty Outpatient Facilities, NEC
- SEC CIK
- 0001443863
No open-market purchases or sales by BioCorRx Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BICX, Q2 2026
No superinvestor reported holding BICX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BioCorRx Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 (view filing) | Jan 12-16 | 5 days | Lucido Louis C.Interim President | PPurchaseCommon Stock, par value $0.001 | +3.13K | $0.70 | +$2.19K | +0.7%474.9K after | 2 lots |
| Jul 6, 2023 (view filing) | Mar 29 | 99 daysLate | Galligan Joseph JDirector, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +171.3K | $1.75 | +$299.8K | +370.4%217.5K after | |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +171.3K | $1.75 | +$299.8K | +163.2%276.3K after | |
| Jan 31, 2023 (view filing) | Jan 30 | 1 day | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +400 | $1.39 | +$554 | +0.4%102.2K after | 2 lots |
| Jan 27, 2023 (view filing) | Jan 26 | 1 day | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +500 | $1.29 | +$645 | +0.5%101.8K after | |
| Jan 25, 2023 (view filing) | Jan 24 | 1 day | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +200 | $1.20 | +$240 | +0.2%101.3K after | |
| Jan 17, 2023 (view filing) | Jan 13 | 4 days | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +4.00K | $1.13 | +$4.50K | +4.1%101.1K after | 2 lots |
| Jan 4, 2023 (view filing) | Dec 30, 2022-Jan 3, 2023 | 5 days | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +2.31K | $1.09 | +$2.51K | +2.4%97.1K after | 3 lots |
| Dec 15, 2022 (view filing) | Dec 12 | 3 daysLate | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +5.00K | $0.834 | +$4.17K | +5.9%89.4K after | 4 lots |
| Oct 11, 2022 (view filing) | Sep 6-Oct 6 | 35 daysLate | Lucido Louis C.Director, 10% Owner | PPurchaseCommon Stock, par value $0.001 | +1.59K | $1.97 | +$3.13K | +1.9%84.4K after | 5 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in BioCorRx Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BICX in 13F filings for Q2 2026.